Human cdk2 with type ii inhibitor Deposition Author(s): Alexander, L.T. , Bountra, C. , Carpenter, E.P. , Cowan-Jacob, S.W. , Edwards, A.M. , Elkins, J.M. , Fedorov, O. , Knapp, S. , Kopec, J. , Krojer, T. , Moebitz, H. , Pike, A.C.W. , Savitsky, P.A. , Szklarz, M.
Date: 2015-04-27 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Homo Sapiens Sequences Data: 5A14_A
Crystal structure of dot1l in complex with inhibitor cpd2 [2-(2-(5-((2-chlorophenoxy)methyl)-1h-tetrazol-1-yl)acetyl)-n-(4-chlorophenyl)hydrazinecarboxamide] Deposition Author(s): Be, C. , Gaul, C. , Moebitz, H. , Scheufler, C.
Date: 2015-09-16 Method: X-RAY DIFFRACTION Resolution: 2.69 Å Organism(s): Homo Sapiens Sequences Data: 5DRT_A , 5DRT_B
Crystal structure of dot1l in complex with inhibitor cpd3 [n-(1-(2-chlorophenyl)-1h-indol-6-yl)-2-(2-(5-(2-chlorophenyl)-1h-tetrazol-1-yl)acetyl)hydrazinecarboxamide] Deposition Author(s): Be, C. , Gaul, C. , Moebitz, H. , Scheufler, C.
Date: 2015-09-16 Method: X-RAY DIFFRACTION Resolution: 2.41 Å Organism(s): Homo Sapiens Sequences Data: 5DRY_A , 5DRY_B
Crystal structure of dot1l in complex with inhibitor cpd10 [6'-chloro-1,4-dimethyl-5'-(2-methyl-6-((4-(methylamino)pyrimidin-2-yl)amino)-1h-indol-1-yl)-[3,3'-bipyridin]-2(1h)-one] Deposition Author(s): Be, C. , Gaul, C. , Moebitz, H. , Scheufler, C.
Date: 2015-09-17 Method: X-RAY DIFFRACTION Resolution: 2.41 Å Organism(s): Homo Sapiens Sequences Data: 5DSX_A , 5DSX_B
Crystal structure of dot1l in complex with inhibitor cpd11 [n4-methyl-n2-(2-methyl-1-(2-phenoxyphenyl)-1h-indol-6-yl)pyrimidine-2,4-diamine] Deposition Author(s): Be, C. , Gaul, C. , Moebitz, H. , Scheufler, C.
Date: 2015-09-17 Method: X-RAY DIFFRACTION Resolution: 2.3 Å Organism(s): Homo Sapiens Sequences Data: 5DT2_A , 5DT2_B
Crystal structure of dot1l in complex with inhibitor cpd1 [4-(2,6-dichlorobenzoyl)-n-methyl-1h-pyrrole-2-carboxamide] Deposition Author(s): Be, C. , Moebitz, H. , Scheufler, C. , Stauffer, F.
Date: 2015-09-18 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Homo Sapiens Sequences Data: 5DTM_A , 5DTM_B
Crystal structure of dot1l in complex with inhibitor cpd3 [(2,6-dichlorophenyl)(quinolin-6-yl)methanone] Deposition Author(s): Be, C. , Moebitz, H. , Scheufler, C. , Stauffer, F.
Date: 2015-09-18 Method: X-RAY DIFFRACTION Resolution: 2.61 Å Organism(s): Homo Sapiens Sequences Data: 5DTQ_A , 5DTQ_B
Crystal structure of dot1l in complex with inhibitor cpd5 [n-(2,6-dichlorophenyl)-4-methoxy-n-methylquinolin-6-amine] Deposition Author(s): Be, C. , Moebitz, H. , Scheufler, C. , Stauffer, F.
Date: 2015-09-18 Method: X-RAY DIFFRACTION Resolution: 2.34 Å Organism(s): Homo Sapiens Sequences Data: 5DTR_A , 5DTR_B
Crystal structure of dot1l in complex with adenosine and inhibitor cpd1 [n6-(2,6-dichlorophenyl)-n6-(pent-2-yn-1-yl)quinoline-4,6-diamine] Deposition Author(s): Be, C. , Gaul, C. , Koch, E. , Moebitz, H. , Scheufler, C. , Stauffer, F.
Date: 2017-01-17 Method: X-RAY DIFFRACTION Resolution: 2.18 Å Organism(s): Homo Sapiens Sequences Data: 5MVS_A , 5MVS_B
Crystal structure of dot1l in complex with inhibitor cpd1 [n6-(2,6-dichlorophenyl)-n6-(pent-2-yn-1-yl)quinoline-4,6-diamine] and inhibitor cpd2 [(r)-1-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine] Deposition Author(s): Be, C. , Gaul, C. , Koch, E. , Moebitz, H. , Scheufler, C. , Stauffer, F.
Date: 2017-01-18 Method: X-RAY DIFFRACTION Resolution: 2.09 Å Organism(s): Homo Sapiens Sequences Data: 5MW3_A , 5MW3_B